tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
RatingsAlnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
2h ago
ALNY
Alnylam Pharma’s Strong Q3 Performance and Promising Outlook Reinforce Buy Rating Despite Legal Concerns
PremiumRatings
Alnylam Pharma’s Strong Q3 Performance and Promising Outlook Reinforce Buy Rating Despite Legal Concerns
7h ago
ALNY
Alnylam price target raised to $495 from $475 at Morgan Stanley
PremiumThe Fly
Alnylam price target raised to $495 from $475 at Morgan Stanley
9h ago
ALNY
Alnylam price target lowered to $549 from $550 at Jefferies
PremiumThe Fly
Alnylam price target lowered to $549 from $550 at Jefferies
9h ago
ALNY
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
PremiumRatings
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
13h ago
ALNY
Alnylam reports Q3 EPS $1.84, consensus $1.75
PremiumThe FlyAlnylam reports Q3 EPS $1.84, consensus $1.75
14h ago
ALNY
ALNY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALNY Upcoming Earnings Report: What to Expect?
3d ago
ALNY
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
3d ago
ALNY
Alnylam’s ZENITH Study: A New Horizon in Cardiovascular Treatment
PremiumCompany Announcements
Alnylam’s ZENITH Study: A New Horizon in Cardiovascular Treatment
3d ago
ALNY
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-TTRSC04: Market Implications
PremiumCompany Announcements
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-TTRSC04: Market Implications
3d ago
ALNY
Alnylam price target raised to $450 from $325 at Cantor Fitzgerald
PremiumThe Fly
Alnylam price target raised to $450 from $325 at Cantor Fitzgerald
9d ago
ALNY
Alnylam price target raised to $535 from $459 at Truist
PremiumThe Fly
Alnylam price target raised to $535 from $459 at Truist
14d ago
ALNY
Alnylam and Regeneron Join Forces in Promising Alzheimer’s Study
PremiumCompany AnnouncementsAlnylam and Regeneron Join Forces in Promising Alzheimer’s Study
21d ago
ALNY
REGN
Alnylam price target raised to $475 from $405 at Morgan Stanley
Premium
The Fly
Alnylam price target raised to $475 from $405 at Morgan Stanley
25d ago
ALNY
Alnylam price target raised to $495 from $441 at Stifel
Premium
The Fly
Alnylam price target raised to $495 from $441 at Stifel
25d ago
ALNY
Alnylam Pharma Secures $500M Credit Agreement
PremiumCompany Announcements
Alnylam Pharma Secures $500M Credit Agreement
27d ago
8K
ALNY
Alnylam doses first patient in ZENITH trial
PremiumThe Fly
Alnylam doses first patient in ZENITH trial
30d ago
ALNY
Alnylam announces results from HELIOS-B Phase 3 study of AMVUTTRA
PremiumThe Fly
Alnylam announces results from HELIOS-B Phase 3 study of AMVUTTRA
1M ago
ALNY
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-AGT01 RVR
PremiumCompany Announcements
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-AGT01 RVR
1M ago
ALNY
Alnylam price target raised to $500 from $435 at RBC Capital
PremiumThe FlyAlnylam price target raised to $500 from $435 at RBC Capital
1M ago
ALNY
Alnylam price target raised to $520 from $453 at BofA
Premium
The Fly
Alnylam price target raised to $520 from $453 at BofA
1M ago
ALNY
Alnylam Pharma: Promising Growth Driven by ATTR-CM Franchise and siRNA Platform Expansion
Premium
Ratings
Alnylam Pharma: Promising Growth Driven by ATTR-CM Franchise and siRNA Platform Expansion
1M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >